Rossmore Private Capital Horizon Therapeutics Public LTD CO Transaction History

Rossmore Private Capital

  • $804 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$62.39 - $113.8 $200,209 - $365,184
3,209 New
3,209 $365,000
Q2 2022

Aug 11, 2022
BUY
$79.4 - $116.36 $51,610 - $75,634
650 Added 26.22%
3,129 $250,000
Q1 2021

May 10, 2021
BUY
$71.83 - $95.48 $178,066 - $236,694
2,479 New
2,479 $228,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email